Z ZUMUTOR BIOLOGICS INC. Trademark Information

Zumutor Biologics Inc

(Based on Use in Commerce) Analeptics; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial substances for medical purposes; Antibiotic preparations; Antibiotics; Antidiabetic preparations; Biological preparations for the treatment of...

(Based on Use in Commerce) Bacteriological research; Biochemical research and development; Biological research; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Ph...

This is a brand page for the Z ZUMUTOR BIOLOGICS INC. trademark by Zumutor Biologics Inc  in Woburn, MA, 01801.

Write a review about a product or service associated with this Z ZUMUTOR BIOLOGICS INC. trademark. Or, contact the owner Zumutor Biologics Inc of the Z ZUMUTOR BIOLOGICS INC. trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the Z ZUMUTOR BIOLOGICS INC. trademark.

Status Update! On Tuesday, November 22, 2016, status on the Z ZUMUTOR BIOLOGICS INC. trademark changed to RESPONSE AFTER NON-FINAL ACTION - ENTERED.

On Friday, February 26, 2016, a U.S. federal trademark registration was filed for Z ZUMUTOR BIOLOGICS INC. by Zumutor Biologics Inc, Woburn, MA 01801. The USPTO has given the Z ZUMUTOR BIOLOGICS INC. trademark serial number of 86921302. The current federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED. The correspondent listed for Z ZUMUTOR BIOLOGICS INC. is CHATTERJEE SOHANG of CHATTERJEE SOHANG, 100 TRADECENTER,CENTURYSUITS,SUITE G-700, WOBURN, MA 01801 . The Z ZUMUTOR BIOLOGICS INC. trademark is filed in the category of Pharmaceutical Products , Computer & Software Services & Scientific Services . The description provided to the USPTO for Z ZUMUTOR BIOLOGICS INC. is (Based on Use in Commerce) Analeptics; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial substances for medical purposes; Antibiotic preparations; Antibiotics; Antidiabetic preparations; Biological preparations for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Bone fillers consisting of living materials; Contrast media for in-vivo imaging; Cord blood for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, oncology, rheumatoid arthritis, diabetes and metabolic disorders; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Dietetic sugar substitutes for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Hypoglycemic agents; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Insulin; Insulin injectors sold filled with insulin; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines for the treatment of gastrointestinal diseases; Organotherapeutics; Pancreas hormone preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for the treatment and prevention of metabolic disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of rheumatoid arthritis; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, elixirs for the treatment of oncology; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Placebo pills for medical use; Preparations for detecting genetic predispositions for medical purposes; Probiotic supplements; Protein arrays for medical diagnosis purposes; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radioactive substances for use in nuclear medicine; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Reagents and media for medical and veterinary diagnostic purposes; Surgical implants comprised of living tissues; Syrups for pharmaceutical purposes for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Tumor suppressing agents(Based on 44(d) Priority Application) Analeptics; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial substances for medical purposes; Antibiotic preparations; Antibiotics; Antidiabetic preparations; Biological preparations for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Bone fillers consisting of living materials; Contrast media for in-vivo imaging; Cord blood for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, oncology, rheumatoid arthritis, diabetes and metabolic disorders; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Dietetic sugar substitutes for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Hypoglycemic agents; In-vivo diagnostic agent used for detection and monitoring.

Word mark: Z ZUMUTOR BIOLOGICS INC.
Status/Status Date:
RESPONSE AFTER NON-FINAL ACTION - ENTERED
11/22/2016
Serial Number: 86921302
Filing Date: 2/26/2016
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: (Based on Use in Commerce) Analeptics; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial substances for medical purposes; Antibiotic preparations; Antibiotics; Antidiabetic preparations; Biological preparations for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Bone fillers consisting of living materials; Contrast media for in-vivo imaging; Cord blood for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, oncology, rheumatoid arthritis, diabetes and metabolic disorders; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Dietetic sugar substitutes for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Hypoglycemic agents; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Insulin; Insulin injectors sold filled with insulin; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines for the treatment of gastrointestinal diseases; Organotherapeutics; Pancreas hormone preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for the treatment and prevention of metabolic disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of rheumatoid arthritis; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, elixirs for the treatment of oncology; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Placebo pills for medical use; Preparations for detecting genetic predispositions for medical purposes; Probiotic supplements; Protein arrays for medical diagnosis purposes; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radioactive substances for use in nuclear medicine; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Reagents and media for medical and veterinary diagnostic purposes; Surgical implants comprised of living tissues; Syrups for pharmaceutical purposes for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Tumor suppressing agents(Based on 44(d) Priority Application) Analeptics; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial substances for medical purposes; Antibiotic preparations; Antibiotics; Antidiabetic preparations; Biological preparations for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Bone fillers consisting of living materials; Contrast media for in-vivo imaging; Cord blood for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, oncology, rheumatoid arthritis, diabetes and metabolic disorders; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Dietetic sugar substitutes for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Hypoglycemic agents; In-vivo diagnostic agent used for detection and monitoring
Mark Description: The mark consists of a "RED" colored shield with a white colored "Z", the wording "ZUMUTOR" in orange to the right of the shiled, and the wordings Biologics Inc in black below the word zumutor "ALL IN A WHITE BACKGROUND".
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner: Zumutor Biologics Inc
Woburn, MA 01801
Mark Drawing Code: Drawing/Design + Words
Design Search:
Shields or crests with letters, punctuation or inscriptions contained therein or superimposed thereon (Heraldry, flags, crowns, crosses, arrows and symbols - Shields, crests) see more design...
Register Type: Principal
Disclaimer: ("BIOLOGICS INC")
Correspondent:
CHATTERJEE SOHANG
100 TRADECENTER,CENTURYSUITS,SUITE G-700
WOBURN, MA 01801

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your Z ZUMUTOR BIOLOGICS INC. trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Legalforce RAPC - #1 U.S. Trademark Filing since 2010.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global IP Attorneys - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
Current Trademark Status:
11/22/2016
RESPONSE AFTER NON-FINAL ACTION - ENTERED
Free Trademark Search:
Correspondent Search:

CHATTERJEE SOHANG is a correspondent of Z ZUMUTOR BIOLOGICS INC. trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Keep Track of this Brand.

Trademark Watch Services

Keep track of how your trademark is being used. Available in the United States and in more than 176 countries. Round-the-clock monitoring. Monthly report on potential infringement.

Trademark Watch Services read more...
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!